General Catalyst Group VIII Supplemental, L.P.'s Net Worth
$164 Million
Who is General Catalyst Group VIII Supplemental, L.P.?
General Catalyst Group VIII Supplemental, L.P. has an estimated net worth of $164 Million. This is based on reported shares across multiple companies, which include Lemonade, Inc., Samsara Inc., and Livongo Health, Inc..
SEC CIK
General Catalyst Group VIII Supplemental, L.P.'s CIK is 0001663855
Past Insider Trading and Trends
2020 was General Catalyst Group VIII Supplemental, L.P.'s most active year for acquiring shares with 7 total transactions. General Catalyst Group VIII Supplemental, L.P.'s most active month to acquire stocks was the month of June. 2020 was General Catalyst Group VIII Supplemental, L.P.'s most active year for disposing of shares, totalling 15 transactions. General Catalyst Group VIII Supplemental, L.P.'s most active month to dispose stocks was the month of June. 2019 saw General Catalyst Group VIII Supplemental, L.P. paying a total of $74,999,988.00 for 19,622,308 shares, this is the most they've acquired in one year. In 2023 General Catalyst Group VIII Supplemental, L.P. cashed out on 37,603,856 shares for a total of $56,580,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lemonade, Inc. (LMND) Snapshot price: $15.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.22M |
—
|
—
| 3.22M |
Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Samsara Inc. (IOT) Snapshot price: $32.435
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13 - Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15 - Mar 20
| |||
Form 4
|
—
|
0
|
$18.86 | -$56,580,000.00 | 3M |
Mar 13
| |||
Form 4
|
∞
| 2M |
$23.00 | $46,000,000.00 | 2M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Livongo Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -18.46M |
—
|
—
|
0
|
Oct 30
| |||
Form 4
| +0.33% | 3.17K |
—
|
—
| 974.24K |
Sep 10
| |||
Form 4
| -75.59% | -2.02M |
—
|
—
| 653.92K |
Jul 29
| |||
Form 4
| +0.40% | 3.91K |
—
|
—
| 971.06K |
Jun 24
| |||
Form 4
| -12.54% | -2.00M |
—
|
—
| 13.94M |
May 15 - May 19
| |||
Form 4
| -1.85% | -300.00K |
$52.88 | -$15,864,968.85 | 15.94M |
May 11
| |||
Form 4
| +621.67% | 19.62M |
$28.00 | $74,999,988.00 | 22.78M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |